Novo Nordisk is Denmark’s big little problem: In this week's Viewsroom podcast, Breakingviews columnists discuss the future of weight‑loss pills and Novo’s place in it
Novo Nordisk is Denmark’s big little problem: In this week's Viewsroom podcast, Breakingviews columnists discuss the future of weight‑loss pills and Novo’s place in it